Video
Sperm parameters maintained in most men taking nasal testosterone gel
Author(s):
Ranjith Ramasamy, MD, discusses a recent study evaluating the testosterone nasal gel Natesto.
Ranjith Ramasamy, MD, discusses findings from the recent Journal of Urology paper, “Effect of Natesto on Reproductive Hormones, Semen Parameters, and Hypogonadal Symptoms: A Single Center, Open Label, Single Arm Trial.” Ramasamy is director of male reproductive medicine and surgery and associate professor of urology at the University of Miami Miller School of Medicine.
More videos:
What quality registry data reveal about urethral stricture treatment
Dr. North discusses the gender pay gap in urology
Telemedicine appears viable for pediatric post-op visits in urology
Related Videos
An expert discusses patient counseling in wake of FDA’s labeling changes for testosterone
FDA testosterone labeling changes: How will they affect prescribing?
Landon Trost, MD, on the impact of the FDA labeling changes for testosterone products
How urologists can discuss testosterone labeling changes with patients
John P. Mulhall, MD, shares his reaction to the FDA’s testosterone labeling changes
An expert shares their approach to testosterone therapy in men with hypogonadism
Helen L. Bernie, DO, MPH, on the FDA’s labeling changes for testosterone products
Dayna R. Smerina and Amy M. Pearlman, MD, discuss their research in sexual medicine
Top 10 Urology Times videos of 2024
Does varicocele affect prostate cancer outcomes?
Related Content
